cervical squamous cell carcinoma
cervical squamous cell carcinoma
Explore linked clinical trials. Standard reference: MONDO:000614314 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes | Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, cervical squamous cell carcinoma, digestive system disorder, digestive system neoplasm, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm | Recruiting | Phase 2 | 2026-09-29 | NCT07848243 | |
| Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, cervical squamous cell carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell lung carcinoma, squamous cell neoplasm | Active, not recruiting | Not stated | 2026-09-18 | NCT07147361 | |
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, anal squamous cell carcinoma, anus disorder, anus neoplasm, benign urinary system neoplasm, carcinoma, cervical squamous cell carcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm, squamous cell carcinoma, squamous cell carcinoma of penis, squamous cell lung carcinoma, squamous cell neoplasm, tongue squamous cell carcinoma, urethra squamous cell carcinoma, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, vaginal squamous cell carcinoma, vulvar squamous cell carcinoma | Recruiting | Phase 1 | 2026-09-15 | NCT07217171 | |
| A Study of IDP-001 in Advanced or Metastatic Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, anal squamous cell carcinoma, anus disorder, anus neoplasm, carcinoma, cervical squamous cell carcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm, skin squamous cell carcinoma, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-03 | NCT07602842 | |
| Feasibility Study of Blood Biomarker Identification in Cervical Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervical adenocarcinoma, cervical squamous cell carcinoma, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Not stated | 2026-09-02 | NCT07796672 | |
| Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervical adenocarcinoma, cervical adenosquamous carcinoma, cervical squamous cell carcinoma, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder, vaginal adenocarcinoma, vaginal cancer, vaginal carcinoma, vaginal disorder | Active, not recruiting | Phase 3 | 2026-08-21 | NCT02466971 | |
| External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer | cervical adenocarcinoma, cervical adenosquamous carcinoma, cervical squamous cell carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-08-12 | NCT06543576 | |
| A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, cervical squamous cell carcinoma, cholangiocarcinoma, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, intestinal disorder, intrahepatic cholangiocarcinoma, neoplasm, rectal disorder, transitional cell carcinoma, urothelial carcinoma | Recruiting | Phase 1 / Phase 2 | 2026-07-02 | NCT07169734 | |
| A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, cervical squamous cell carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT06747585 | |
| A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cervical squamous cell carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-05-27 | NCT05910827 | |
| Intra-lesional Tumor Boost for Bulky Cervical Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, carcinoma, cervical squamous cell carcinoma, cervix disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, squamous cell carcinoma, squamous cell neoplasm, uterine disorder | Recruiting | Phase 2 | 2026-02-27 | NCT07435376 | |
| Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. | Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, adenoma, benign urinary system neoplasm, breast disorder, breast neoplasm, carcinoma, cervical squamous cell carcinoma, digestive system disorder, digestive system neoplasm, endocrine system disorder, endometrium neoplasm, epithelial neoplasm, esophageal adenocarcinoma, esophageal cancer, esophageal disorder, esophageal squamous cell carcinoma, estrogen-receptor positive breast cancer, female reproductive system disorder, female reproductive system neoplasm, gastroesophageal cancer, gonadal disorder, head and neck squamous cell carcinoma, hepatocellular carcinoma, kidney cancer, kidney disorder, liver disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, melanocytic neoplasm, melanoma, mesothelial neoplasm, mesothelioma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, pancreatic adenocarcinoma, primitive neuroectodermal tumor, prostate cancer, prostate disorder, renal cell carcinoma, skin disorder, skin neoplasm, squamous cell carcinoma, squamous cell neoplasm, triple-negative breast carcinoma, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, uterine disorder | Active, not recruiting | Phase 1 | 2025-11-28 | NCT03983954 | |
| Primary Cervical Cancer Screening by Self-sampling HPV Test | Atypical Squamous Cells of Undetermined Significance, Atypical Squamous Cells of the Cervix, Cervical Intraepithelial Neoplasia, Grade III, DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, High-Grade Squamous Intraepithelial Lesions, Infections, Low-Grade Squamous Intraepithelial Lesions, Morphological and Microscopic Findings, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial Lesions, Tumor Virus Infections, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, adenocarcinoma, adenocarcinoma in situ, carcinoma, cervical adenocarcinoma, cervical squamous cell carcinoma, cervical squamous intraepithelial neoplasia, cervix disorder, dysplasia of cervix, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, human papilloma virus infection, in situ carcinoma, infectious disease, neoplasm, precancerous condition, sexually transmitted disease, uterine disorder, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Not stated | 2023-12-21 | NCT05613283 | |
| Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma | cervical squamous cell carcinoma | Not yet recruiting | Not stated | 2021-07-26 | NCT04976478 |